AN2 Therapeutics (ANTX)

• Market cap: $32.5M
• 1 day: 0.85%
• 5 days: -7.03%
• 1 month: -7.75%
• 3 months: 9.17%
• 6 months: -5.56%
• Year to date: -14.39%
• 1 year: 15.53%
• 5 years: -92.27%
• 10 years: -92.27%
• Sector: Healthcare
• Industry: Biotechnology

About: AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.

Employees: 36